Parathyroid Disease Clinical Trial
Official title:
Establishment of a Parathyroid Tissue Bank
NCT number | NCT03051126 |
Other study ID # | LAB08-0034 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | July 9, 2009 |
Est. completion date | July 1, 2025 |
To develop a tissue bank library for patients with parathyroid disease who have undergone surgery and/or biopsy, and/or who may undergo surgical intervention at M. D. Anderson Cancer Center or outside centers, and/or all patients seen through the Parathyroid Center at participating sites, whether or not the patients undergo treatment for their disease. The tissue bank will contain both normal parathyroid tissue and diseased tissue, and will provide a resource for the ongoing study of parathyroid disease and management.
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | July 1, 2025 |
Est. primary completion date | July 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: 1. Eligible participants will include patients presenting at MD Anderson Cancer who are scheduled for surgical treatment of parathyroid disease and/or patients with MEN1, and/or those presenting with hyperparathyroidism and/or pancreatic lesion, who are scheduled for pancreas tumor intervention, as well as patients having had surgery and who have had residual tissue stored under LAB02-518, LAB03-0320 or prior front door consents, or who have had surgery at other centers and provide signed authorization to obtain the tissue from the outside institution. 2. In addition, eligible participants may include family members of MD Anderson patients who have been diagnosed with parathyroid disease and who have had surgery at other centers, and who provide a signed authorization to obtain the tissue from outside facilities AND/OR who begin care at MD Anderson and will be having intervention at MD Anderson. Exclusion Criteria: N/A |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas MD Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tissue Collection Obtained During Parathyroid and/or Pancreas Tumor Intervention to Establish a Tissue Bank Library for Ongoing Study of Parathyroid Disease and Management | 15 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03044600 -
Gene Expression in Hyperparathyroidism
|
||
Completed |
NCT01805856 -
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
|
N/A | |
Completed |
NCT01794676 -
Genetic Evaluation of Families With Endocrine Cancers
|
N/A | |
Completed |
NCT01545622 -
Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease
|
N/A | |
Withdrawn |
NCT00528502 -
Lidocaine Supplement for Minimal Invasive Parathyroid Surgery
|
Phase 3 | |
Completed |
NCT01539499 -
Complications of Endocrine Surgery: Data From the United HealthSystem Consortium
|
N/A | |
Completed |
NCT01539486 -
Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy
|
||
Completed |
NCT01574287 -
Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
|
N/A |